Skip to content

Investing in Our People: Career Development at Scailyte

Investing in Our People: Career Development at Scailyte

Investing in Our People: Career Development at Scailyte

Investing in Our People: Career Development at Scailyte

At Scailyte, our commitment to nurturing talent and fostering professional growth is evident. We believe that investing in our people is not just good for business, but it’s the right thing to do. Our dedication to career development shines through in several ways:

Performance Reviews: All our teammates undergo a performance review at least annually. This process helps Scailyters understand their strengths, discuss how to nurture them with their line manager and identify areas for improvement. This process also supports the alignment of teammates goals with our organizational objectives.

Individual Development Plans: We recognize that each team member is empowered to lead his/her career trajectory in a unique manner. That’s why all teammates have individual development plans in place. These tailored roadmaps support our Scailyters on their journey towards personal and professional growth.

Skills Development Training: We’re dedicated to equipping our team with the skills they need to excel. Through skills development training, we ensure that our teammates are not just keeping pace with industry trends but also leading the way.

Continuous Learning: Our commitment to growth extends to a comprehensive program that encompasses meticulous onboarding, diverse on-the-job training opportunities, active involvement in business decisions, leadership role assignments, peer training, structured mentoring, and coaching relationships. It’s all part of our mission to empower every Scailyte team member for success.

Thank you to our amazing team for making Scailyte a place where talent is nurtured, careers are built, and futures are bright. Stay tuned for more updates on our commitment to career development!

About Scailyte

Scailyte is an ETH Zürich spin-off with a best-in-class artificial intelligence platform for the discovery of complex disease patterns from single-cell data. Our solution provides unprecedented insight into the disease and patients’ biology and enables the discovery of new clinically-relevant biomarker signatures by uncovering human’s hidden “single-cell” secrets. 

Scailyte’s proprietary best-in-class data analysis platform ScaiVision™ associates multimodal single-cell datasets (RNA-/TCR-/BCR-seq, proteomics, etc.) with clinical endpoints, such as disease diagnosis, progression, severity, treatment response, and toxicity response to identify ultra-sensitive biomarker signatures and cell functionality states. The performance and clinically-relevant applications of Scailyte’s platform ScaiVision have been demonstrated in well established CAR-T cell therapies and various clinical projects in Oncology and Immunology.

For more information, visit www.scailyte.com and connect on social media @LinkedIn and @Twitter.

ScailyteTM and ScaiVisionTM are registered trademarks proprietary to Scailyte AG.

Recent News

Inside Scailyte - Episode 10: Meet Dennis Göhlsdorf

In our latest episode of "Inside Scailyte," we're excited to introduce you to Dennis Göhlsdorf, our...

Read more

Recent News

Precision Med TRI-CON 2024

Join us for our presentation on "Enabling Precision Medicine by Combining Single-Cell Multi-Omics Da...

Read more

Recent News

Inside Scailyte - Episode 9: Meet Shaoline Sheppard

In the latest episode of "Inside Scailyte," we're thrilled to introduce you to Shaoline Sheppard, ou...

Read more

Recent News

NextGen Omics US 2024

Scailyte is headed to NextGen Omics US 2024 in Boston, MA on March 21-22. Join us as we showcase our...

Read more

Recent News

AI-driven single-cell data analysis identifies a cell signature predictive of neurotoxicity and clinical response in CAR-T cell therapy of DLBCL

In our latest white paper, "AI-driven single-cell data analysis identifies a cell signature predicti...

Read more

Recent News

Inside Scailyte - Episode 8: Meet Sajid Maqbool

Meet Sajid Maqbool, our Information Technology Engineer at Scailyte AG. In our latest episode of "In...

Read more

Recent News

Inside Scailyte – Episode 7: Meet Anna Dimitrova

Meet Anna Dimitrova, our Chief Financial Officer at Scailyte AG. In our latest episode of "Inside Sc...

Read more

Recent News

ScaiPod: Revolutionizing Immuno-Oncology With Multi-Omics and AI at Scale

ScaiPod's mission is clear: develop next-generation clinical biomarkers for precise immuno-oncology ...

Read more

Recent News

01 /04

Inside Scailyte - Episode 10: Meet Dennis Göhlsdorf

In our latest episode of "Inside Scailyte," we're excited to introduce you to Dennis Göhlsdorf, our...

Read more

Precision Med TRI-CON 2024

Join us for our presentation on "Enabling Precision Medicine by Combining Single-Cell Multi-Omics Da...

Read more

Recent News

02 /04

Inside Scailyte - Episode 9: Meet Shaoline Sheppard

In the latest episode of "Inside Scailyte," we're thrilled to introduce you to Shaoline Sheppard, ou...

Read more

NextGen Omics US 2024

Scailyte is headed to NextGen Omics US 2024 in Boston, MA on March 21-22. Join us as we showcase our...

Read more

Recent News

03 /04

AI-driven single-cell data analysis identifies a cell signature predictive of neurotoxicity and clinical response in CAR-T cell therapy of DLBCL

In our latest white paper, "AI-driven single-cell data analysis identifies a cell signature predicti...

Read more

Inside Scailyte - Episode 8: Meet Sajid Maqbool

Meet Sajid Maqbool, our Information Technology Engineer at Scailyte AG. In our latest episode of "In...

Read more

Recent News

04 /04

Inside Scailyte – Episode 7: Meet Anna Dimitrova

Meet Anna Dimitrova, our Chief Financial Officer at Scailyte AG. In our latest episode of "Inside Sc...

Read more

ScaiPod: Revolutionizing Immuno-Oncology With Multi-Omics and AI at Scale

ScaiPod's mission is clear: develop next-generation clinical biomarkers for precise immuno-oncology ...

Read more

Recent News